Intuitive Surgical Operating Income Growth & History (ISRG)
Intuitive Surgical's operating income was $2.95B for fiscal 2025.
View full Intuitive Surgical company overviewIntuitive Surgical annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.95B | $596.6M | +25.40% |
| 2024 | 2024-12-31 | $2.35B | $582.1M | +32.95% |
| 2023 | 2023-12-31 | $1.77B | $189.7M | +12.03% |
| 2022 | 2022-12-31 | $1.58B | −$243.9M | −13.39% |
| 2021 | 2021-12-31 | $1.82B | $771.2M | +73.46% |
| 2020 | 2020-12-31 | $1.05B | −$324.7M | −23.62% |
| 2019 | 2019-12-31 | $1.37B | $175.1M | +14.60% |
| 2018 | 2018-12-31 | $1.20B | $136.5M | +12.84% |
| 2017 | 2017-12-31 | $1.06B | $113.2M | +11.92% |
| 2016 | 2016-12-31 | $949.7M | $209.7M | +28.34% |
| 2015 | 2015-12-31 | $740.0M | $195.2M | +35.83% |
| 2014 | 2014-12-31 | $544.8M | −$307.7M | −36.09% |
| 2013 | 2013-12-31 | $852.5M | −$25.6M | −2.92% |
| 2012 | 2012-12-31 | $878.1M | $183.3M | +26.38% |
| 2011 | 2011-12-31 | $694.8M | $139.6M | +25.14% |
| 2010 | 2010-12-31 | $555.2M | $177.8M | +47.11% |
| 2009 | 2009-12-31 | $377.4M | $66.6M | +21.43% |
| 2008 | 2008-12-31 | $310.8M | $104.1M | +50.33% |
| 2007 | 2007-12-31 | $206.7M | — | — |
Intuitive Surgical quarterly operating income
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $971.9M | $228.5M | +30.74% |
| Q1 2026 | 2026-03-31 | $855.3M | $277.2M | +47.95% |
| Q4 2025 | 2025-12-31 | $864.3M | $129.4M | +17.61% |
| Q3 2025 | 2025-09-30 | $759.7M | $182.4M | +31.60% |
| Q2 2025 | 2025-06-30 | $743.4M | $176.1M | +31.04% |
| Q1 2025 | 2025-03-31 | $578.1M | $108.7M | +23.16% |
| Q4 2024 | 2024-12-31 | $734.9M | $284.7M | +63.24% |
| Q3 2024 | 2024-09-30 | $577.3M | $111.5M | +23.94% |
| Q2 2024 | 2024-06-30 | $567.3M | $104.1M | +22.47% |
| Q1 2024 | 2024-03-31 | $469.4M | $81.8M | +21.10% |
| Q4 2023 | 2023-12-31 | $450.2M | $77.7M | +20.86% |
| Q3 2023 | 2023-09-30 | $465.8M | $66.9M | +16.77% |
| Q2 2023 | 2023-06-30 | $463.2M | $65.6M | +16.50% |
| Q1 2023 | 2023-03-31 | $387.6M | −$20.5M | −5.02% |
| Q4 2022 | 2022-12-31 | $372.5M | −$77.9M | −17.30% |
| Q3 2022 | 2022-09-30 | $398.9M | −$43.7M | −9.87% |
| Q2 2022 | 2022-06-30 | $397.6M | −$113.6M | −22.22% |
| Q1 2022 | 2022-03-31 | $408.1M | −$8.7M | −2.09% |
| Q4 2021 | 2021-12-31 | $450.4M | $34.6M | +8.32% |
| Q3 2021 | 2021-09-30 | $442.6M | $172.2M | +63.68% |
| Q2 2021 | 2021-06-30 | $511.2M | $430.6M | +534.24% |
| Q1 2021 | 2021-03-31 | $416.8M | $133.8M | +47.28% |
| Q4 2020 | 2020-12-31 | $415.8M | $18.2M | +4.58% |
| Q3 2020 | 2020-09-30 | $270.4M | −$95.3M | −26.06% |
| Q2 2020 | 2020-06-30 | $80.6M | −$278.4M | −77.55% |
| Q1 2020 | 2020-03-31 | $283.0M | $30.8M | +12.21% |
| Q4 2019 | 2019-12-31 | $397.6M | $65.6M | +19.76% |
| Q3 2019 | 2019-09-30 | $365.7M | $52.4M | +16.73% |
| Q2 2019 | 2019-06-30 | $359.0M | $81.6M | +29.42% |
| Q1 2019 | 2019-03-31 | $252.2M | −$24.5M | −8.85% |
| Q4 2018 | 2018-12-31 | $332.0M | $3.0M | +0.91% |
| Q3 2018 | 2018-09-30 | $313.3M | $32.7M | +11.65% |
| Q2 2018 | 2018-06-30 | $277.4M | $17.5M | +6.73% |
| Q1 2018 | 2018-03-31 | $276.7M | $83.3M | +43.07% |
| Q4 2017 | 2017-12-31 | $329.0M | $60.1M | +22.35% |
| Q3 2017 | 2017-09-30 | $280.6M | $24.2M | +9.44% |
| Q2 2017 | 2017-06-30 | $259.9M | $14.5M | +5.91% |
| Q1 2017 | 2017-03-31 | $193.4M | $14.4M | +8.04% |
| Q4 2016 | 2016-12-31 | $268.9M | $23.0M | +9.35% |
| Q3 2016 | 2016-09-30 | $256.4M | $66.5M | +35.02% |
| Q2 2016 | 2016-06-30 | $245.4M | $71.6M | +41.20% |
| Q1 2016 | 2016-03-31 | $179.0M | $48.6M | +37.27% |
| Q4 2015 | 2015-12-31 | $245.9M | $59.8M | +32.13% |
| Q3 2015 | 2015-09-30 | $189.9M | $30.8M | +19.36% |
| Q2 2015 | 2015-06-30 | $173.8M | $30.8M | +21.54% |
| Q1 2015 | 2015-03-31 | $130.4M | $73.8M | +130.39% |
| Q4 2014 | 2014-12-31 | $186.1M | −$22.5M | −10.79% |
| Q3 2014 | 2014-09-30 | $159.1M | −$15.1M | −8.67% |
| Q2 2014 | 2014-06-30 | $143.0M | −$75.5M | −34.55% |
| Q1 2014 | 2014-03-31 | $56.6M | −$194.6M | −77.47% |
| Q4 2013 | 2013-12-31 | $208.6M | −$39.5M | −15.92% |
| Q3 2013 | 2013-09-30 | $174.2M | −$37.2M | −17.60% |
| Q2 2013 | 2013-06-30 | $218.5M | −$6.8M | −3.02% |
| Q1 2013 | 2013-03-31 | $251.2M | $57.9M | +29.95% |
| Q4 2012 | 2012-12-31 | $248.1M | $48.6M | +24.36% |
| Q3 2012 | 2012-09-30 | $211.4M | $32.5M | +18.17% |
| Q2 2012 | 2012-06-30 | $225.3M | $57.2M | +34.03% |
| Q1 2012 | 2012-03-31 | $193.3M | $45.0M | +30.34% |
| Q4 2011 | 2011-12-31 | $199.5M | $45.8M | +29.80% |
| Q3 2011 | 2011-09-30 | $178.9M | $46.8M | +35.43% |
| Q2 2011 | 2011-06-30 | $168.1M | $28.4M | +20.33% |
| Q1 2011 | 2011-03-31 | $148.3M | $18.6M | +14.34% |
| Q4 2010 | 2010-12-31 | $153.7M | $25.3M | +19.70% |
| Q3 2010 | 2010-09-30 | $132.1M | $27.6M | +26.41% |
| Q2 2010 | 2010-06-30 | $139.7M | $40.2M | +40.40% |
| Q1 2010 | 2010-03-31 | $129.7M | $84.7M | +188.22% |
| Q4 2009 | 2009-12-31 | $128.4M | — | — |
| Q3 2009 | 2009-09-30 | $104.5M | $19.5M | +22.89% |
| Q2 2009 | 2009-06-30 | $99.5M | $21.3M | +27.25% |
| Q1 2009 | 2009-03-31 | $45.0M | — | — |
| Q3 2008 | 2008-09-30 | $85.0M | — | — |
| Q2 2008 | 2008-06-30 | $78.2M | — | — |
Intuitive Surgical operating income trends
Over the last five fiscal years, Intuitive Surgical's operating income increased from $1.05B to $2.95B, a change of $1.90B. The latest reported quarter, Q2 2026, shows $971.9M.
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Intuitive Surgical source filings ↗Community posts
Intuitive’s surgical growth is offset in GAAP earnings by litigation charge
Intuitive Surgical ($ISRG) generated quarterly revenue of $3.05 billion, up 22%, as total procedures increased 15%. Da Vinci procedures rose 14% and Ion procedures increased 31%, while system placements reached 546 compared with 427 a year ...